Evidence Based Medicine
Demand High Levels of Evidence to Support Clinical Decisions
The practice of Evidence-Based Medicine is dependent on the use of the best available high level evidence. Below is evidence in support of the BARDEX® I.C.Silver Alloy Anit-Infective Foley Catheter with Bacti-Guard®* silver alloy coating and BARD® Hydrogel.

Click here for a PDF of the chart shown above.
Hierarchy of Evidence-Based Medicine |
|
HIGHER LEVELS OF EVIDENCE
LOWER LEVELS OF EVIDENCE |
RANDOMIZED HUMAN STUDIES |
Maki 2001 |
|
Karchmer 2000 |
|
SYSTEMATIC REVIEWS AND META ANALYSIS |
|
Schumm 2008 |
|
Saint 1998 |
|
3RD PARTY RECOMMENDATIONS |
|
APIC: CAUTI Prevention Guidelines 2008WOCN: CAUTI Prevention Guidelines 2008European Association of Urology: Guidelines on Urological Infections 2009 |
|
JAMA, 2002 |
|
HUMAN STUDIES |
|
Newton 2002 |
|
Rupp, 2004 |
|
CASE REPORTS |
|
Lai, 2002 |
|
Gerberding, 2002Hospital-Onset Infections: A Patient Safety Issue ANN INTERN MED, 2002;137:665-670. |
|
ECONOMIC ANALYSIS |
|
Saint, 2000 |
|
Plowman, 2001 |
|
HUMAN STUDIES |
|
Over 20 Single Site abstracts presented at various scientific conferences. |
|
Over 10 Mulit-Site abstracts presented at various scientific conferences. |
|
This site is intended for healthcare professionals. If you are a patient seeking more information regarding Catheter Associated Urinary Tract Infection (CAUTI) prevention, please consult your healthcare provider.




